First patient dosed in second Phase 2 add-on Ketamine Trial in Treatment-Resistant Depression (TRD) - GlobeNewswire

Submitted by Anonymous (not verified) on Wed, 06/08/2022 - 12:20

First patient dosed in second Phase 2 add-on Ketamine Trial in Treatment-Resistant Depression (TRD)  GlobeNewswire